Background - Locations - Brussels

Biosimilars Conference

November 18 - 19, 2009 • Berlin, Germany

With 20 speakers confirmed, this year’s Biosimilars conference is set to be jam-packed. Don’t miss the chance to:

  • Explore the latest developments in the US. What are the upcoming futures and challenges?
  • Revisit the EU Market. Learn what the growth drivers and restraints have been and what products to look out for
  • Evaluate the market from an innovator, biosimilar and dual perspective with presentations from Roche Pharma Research, Intas Pharmaceuticals and Merck Bioventures
  • Discover recent developments and comparability approaches to biosimilar mAbs. Learn the challenges and regulatory requirements that must be considered
  • Update your knowledge on advancements in biosimilar comparability, immunogenicity, formulation and pharmacokinetics
  • Analyse regulatory expectations on a Global basis and discover further information on development costs and the potential future impact in emerging markets
  • Ascertain what the payer’s perception is of the biosimilar market and the pricing and access environment for biosimilars
  • Familiarise yourself with patent law strategies and the ones to watch out for

Kristof Roox will speak about "Application of patent litigation strategies to biosimilars: is there a difference?".

Official Event Website
Crowell & Moring Participant(s):
Kristof Roox
Partner – Brussels
Phone: +
For more information, please visit these areas:

Additional Information

Download Brochure